Literature DB >> 30034608

Targeting Tumor Associated Carbonic Anhydrases IX and XII: Highly Isozyme Selective Coumarin and Psoralen Inhibitors.

Claudia Melis1, Simona Distinto1, Giulia Bianco1, Rita Meleddu1, Filippo Cottiglia1, Benedetta Fois1, Domenico Taverna2, Rossella Angius3, Stefano Alcaro4, Francesco Ortuso4, Marco Gaspari2, Andrea Angeli5, Sonia Del Prete6, Clemente Capasso6, Claudiu T Supuran5, Elias Maccioni1.   

Abstract

A small library of psoralen carboxylic acids and their corresponding benzenesulfonamide derivatives were designed and synthesized to evaluate their activity and selectivity toward tumor associated human carbonic anhydrase (hCA) isoforms IX and XII. Both psoralen acids and sulfonamides exhibited potent inhibition of IX and XII isozymes in the nanomolar concentration range. However, psoralen acids resulted as the most selective in comparison with the corresponding benzenesulfonamide derivatives. Our data indicate that the psoralen scaffold is a promising starting point for the design of highly selective tumor associated hCA inhibitors.

Entities:  

Year:  2018        PMID: 30034608      PMCID: PMC6047168          DOI: 10.1021/acsmedchemlett.8b00170

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  37 in total

1.  Glycosyl coumarin carbonic anhydrase IX and XII inhibitors strongly attenuate the growth of primary breast tumors.

Authors:  Nadia Touisni; Alfonso Maresca; Paul C McDonald; Yuanmei Lou; Andrea Scozzafava; Shoukat Dedhar; Jean-Yves Winum; Claudiu T Supuran
Journal:  J Med Chem       Date:  2011-11-22       Impact factor: 7.446

Review 2.  Carbonic anhydrases: novel therapeutic applications for inhibitors and activators.

Authors:  Claudiu T Supuran
Journal:  Nat Rev Drug Discov       Date:  2008-02       Impact factor: 84.694

3.  Psoralen reverses the P-glycoprotein-mediated multidrug resistance in human breast cancer MCF-7/ADR cells.

Authors:  Jingru Jiang; Xiaohong Wang; Kai Cheng; Wanzhong Zhao; Yitong Hua; Chengfeng Xu; Zhenlin Yang
Journal:  Mol Med Rep       Date:  2016-04-08       Impact factor: 2.952

4.  A novel dimeric coumarin analog and antimycobacterial constituents from Fatoua pilosa.

Authors:  Chun-Ching Chiang; Ming-Jen Cheng; Chien-Fang Peng; Hung-Yi Huang; Ih-Sheng Chen
Journal:  Chem Biodivers       Date:  2010-07       Impact factor: 2.408

5.  Direct Pharmacological Targeting of a Mitochondrial Ion Channel Selectively Kills Tumor Cells In Vivo.

Authors:  Luigi Leanza; Matteo Romio; Katrin Anne Becker; Michele Azzolini; Livio Trentin; Antonella Managò; Elisa Venturini; Angela Zaccagnino; Andrea Mattarei; Luca Carraretto; Andrea Urbani; Stephanie Kadow; Lucia Biasutto; Veronica Martini; Filippo Severin; Roberta Peruzzo; Valentina Trimarco; Jan-Hendrik Egberts; Charlotte Hauser; Andrea Visentin; Gianpietro Semenzato; Holger Kalthoff; Mario Zoratti; Erich Gulbins; Cristina Paradisi; Ildiko Szabo
Journal:  Cancer Cell       Date:  2017-04-10       Impact factor: 31.743

6.  Carbonic anhydrase inhibitors. Design of fluorescent sulfonamides as probes of tumor-associated carbonic anhydrase IX that inhibit isozyme IX-mediated acidification of hypoxic tumors.

Authors:  Alessandro Cecchi; Alzbeta Hulikova; Jaromír Pastorek; Silvia Pastoreková; Andrea Scozzafava; Jean-Yves Winum; Jean-Louis Montero; Claudiu T Supuran
Journal:  J Med Chem       Date:  2005-07-28       Impact factor: 7.446

Review 7.  Carbonic anhydrase IX inhibitors in cancer therapy: an update.

Authors:  Claudiu T Supuran; Jean-Yves Winum
Journal:  Future Med Chem       Date:  2015       Impact factor: 3.808

8.  Inhibitory effects and structural insights for a novel series of coumarin-based compounds that selectively target human CA IX and CA XII carbonic anhydrases.

Authors:  Laura De Luca; Francesca Mancuso; Stefania Ferro; Maria Rosa Buemi; Andrea Angeli; Sonia Del Prete; Clemente Capasso; Claudiu T Supuran; Rosaria Gitto
Journal:  Eur J Med Chem       Date:  2017-11-23       Impact factor: 6.514

9.  Psoralen reverses docetaxel-induced multidrug resistance in A549/D16 human lung cancer cells lines.

Authors:  Ming-Ju Hsieh; Mu-Kuan Chen; Ya-Yen Yu; Gwo-Tarng Sheu; Hui-Ling Chiou
Journal:  Phytomedicine       Date:  2014-04-02       Impact factor: 5.340

Review 10.  Imperatorin-pharmacological meaning and analytical clues: profound investigation.

Authors:  Ewelina Kozioł; Krystyna Skalicka-Woźniak
Journal:  Phytochem Rev       Date:  2016-02-20       Impact factor: 5.374

View more
  14 in total

1.  Investigating the Anticancer Activity of Isatin/Dihydropyrazole Hybrids.

Authors:  Rita Meleddu; Vilma Petrikaite; Simona Distinto; Antonella Arridu; Rossella Angius; Lorenzo Serusi; Laura Škarnulytė; Ugnė Endriulaitytė; Miglė Paškevičiu Tė; Filippo Cottiglia; Marco Gaspari; Domenico Taverna; Serenella Deplano; Benedetta Fois; Elias Maccioni
Journal:  ACS Med Chem Lett       Date:  2018-12-18       Impact factor: 4.345

2.  Design, synthesis and fungicidal evaluation of novel psoralen derivatives containing sulfonohydrazide or acylthiourea moiety.

Authors:  Jingyue Dong; Kun Li; Zeyu Hong; Lei Chen; Liangfu Tang; Lijun Han; Lai Chen; Zhijin Fan
Journal:  Mol Divers       Date:  2022-06-06       Impact factor: 3.364

Review 3.  Thiazole Ring-A Biologically Active Scaffold.

Authors:  Anthi Petrou; Maria Fesatidou; Athina Geronikaki
Journal:  Molecules       Date:  2021-05-25       Impact factor: 4.411

4.  Tuning the Dual Inhibition of Carbonic Anhydrase and Cyclooxygenase by Dihydrothiazole Benzensulfonamides.

Authors:  Rita Meleddu; Simona Distinto; Filippo Cottiglia; Rossella Angius; Marco Gaspari; Domenico Taverna; Claudia Melis; Andrea Angeli; Giulia Bianco; Serenella Deplano; Benedetta Fois; Sonia Del Prete; Clemente Capasso; Stefano Alcaro; Francesco Ortuso; Matilde Yanez; Claudiu T Supuran; Elias Maccioni
Journal:  ACS Med Chem Lett       Date:  2018-09-17       Impact factor: 4.345

5.  Exploring new structural features of the 4-[(3-methyl-4-aryl-2,3-dihydro-1,3-thiazol-2-ylidene)amino]benzenesulphonamide scaffold for the inhibition of human carbonic anhydrases.

Authors:  Simona Distinto; Rita Meleddu; Francesco Ortuso; Filippo Cottiglia; Serenella Deplano; Lisa Sequeira; Claudia Melis; Benedetta Fois; Andrea Angeli; Clemente Capasso; Rossella Angius; Stefano Alcaro; Claudiu T Supuran; Elias Maccioni
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

6.  Carbonic anhydrase modulation of emotional memory. Implications for the treatment of cognitive disorders.

Authors:  Patrizio Blandina; Gustavo Provensi; Maria Beatrice Passsani; Clemente Capasso; Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

7.  Extending the Inhibition Profiles of Coumarin-Based Compounds Against Human Carbonic Anhydrases: Synthesis, Biological, and In Silico Evaluation.

Authors:  Victor Kartsev; Athina Geronikaki; Silvia Bua; Alessio Nocentini; Anthi Petrou; Boris Lichitsky; Mykhaylo Frasinyuk; Janis Leitans; Andris Kazaks; Kaspars Tars; Claudiu T Supuran
Journal:  Molecules       Date:  2019-10-04       Impact factor: 4.411

8.  Coumarins from Magydaris pastinacea as inhibitors of the tumour-associated carbonic anhydrases IX and XII: isolation, biological studies and in silico evaluation.

Authors:  Benedetta Fois; Simona Distinto; Rita Meleddu; Serenella Deplano; Elias Maccioni; Costantino Floris; Antonella Rosa; Mariella Nieddu; Pierluigi Caboni; Claudia Sissi; Andrea Angeli; Claudiu T Supuran; Filippo Cottiglia
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

Review 9.  Coumarin carbonic anhydrase inhibitors from natural sources.

Authors:  Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

Review 10.  Anticancer Potential of Furanocoumarins: Mechanistic and Therapeutic Aspects.

Authors:  Salman Ahmed; Haroon Khan; Michael Aschner; Hamed Mirzae; Esra Küpeli Akkol; Raffaele Capasso
Journal:  Int J Mol Sci       Date:  2020-08-06       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.